Skip to main content
CVSA
NYSE Trade & Services

Covista Beats FY2026 Guidance, Revenue Hits $1.95B; Initiates FY2027 Outlook

Tom Rudovsky · Reported by BusinessWire
More coverage: Education Stocks · Consumer
Sentiment info
Positive
Importance info
8
Price
$125.32
Mkt Cap
$4.229B
52W Low
$86.97
52W High
$156.26
52W Position info
44% above low
Off High info
20% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

CVSA sits 44% above its 52-week low of $86.97.

Summary

Covista reported fiscal year 2026 results that exceeded its own financial guidance, with revenue climbing 9.3% to $1.95 billion and adjusted EPS of $8.25. The company also initiated fiscal year 2027 guidance, signaling confidence in continued growth. Operating income expanded to $383.4 million, and adjusted EBITDA margin improved to 26.7%. The results were accompanied by several strategic announcements: a nursing collaboration with Advocate Health, two new Chamberlain University campuses, and expanded AI certificate offerings with Google Cloud. This follows a series of routine insider sales under 10b5-1 plans in July, which do not detract from the strong operational performance. The beat and new guidance provide a fresh catalyst for the stock, as the market digests the magnitude of the outperformance and the forward outlook.

At the time of this announcement, CVSA was trading at $125.32 on NYSE in the Trade & Services sector, with a market capitalization of approximately $4.2B. The 52-week trading range was $86.97 to $156.26. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: BusinessWire.


Price Chart

Share this article

Copied!

CVSA - Latest Insights

CVSA
Oct 29, 2026, 4:20 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $134.66
Real-time Price: $113.30 info
Change: -$21.36 (-16%) info
Market Cap: $3.768B info
CVSA
Oct 29, 2026, 4:16 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $134.66
Real-time Price: $113.30 info
Change: -$21.36 (-16%) info
Market Cap: $3.768B info
CVSA
Oct 29, 2026, 4:05 PM EDT
Source: BusinessWire
Importance Score:
8
Price at Filing: $128.76
Real-time Price: $113.30 info
Change: -$15.46 (-12%) info
Market Cap: $3.768B info
CVSA
Aug 06, 2026, 4:21 PM EDT
Filing Type: 10-K
Importance Score:
8
Price at Filing: $126.50
Real-time Price: $113.30 info
Change: -$13.20 (-10%) info
Market Cap: $3.768B info
CVSA
Aug 06, 2026, 4:19 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $126.50
Real-time Price: $113.30 info
Change: -$13.20 (-10%) info
Market Cap: $3.768B info